BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32552278)

  • 1. Patient-Level Factors Associated With Lack of Health Care Provider Recommendation for the Human Papillomavirus Vaccine Among Young Cancer Survivors.
    York JM; Klosky JL; Chen Y; Connelly JA; Wasilewski-Masker K; Giuliano AR; Robison LL; Wong FL; Hudson MM; Bhatia S; Landier W
    J Clin Oncol; 2020 Sep; 38(25):2892-2901. PubMed ID: 32552278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Papillomavirus Vaccination Rates in Young Cancer Survivors.
    Klosky JL; Hudson MM; Chen Y; Connelly JA; Wasilewski-Masker K; Sun CL; Francisco L; Gustafson L; Russell KM; Sabbatini G; Flynn JS; York JM; Giuliano AR; Robison LL; Wong FL; Bhatia S; Landier W
    J Clin Oncol; 2017 Nov; 35(31):3582-3590. PubMed ID: 28837404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intent and subsequent initiation of human papillomavirus vaccine among young cancer survivors.
    Cherven B; Castellino SM; Chen Y; Wong FL; York JM; Wasilewski-Masker K; Hudson MM; Bhatia S; Klosky JL; Landier W
    Cancer; 2019 Nov; 125(21):3810-3817. PubMed ID: 31291010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey.
    Sonawane K; Zhu Y; Montealegre JR; Lairson DR; Bauer C; McGee LU; Giuliano AR; Deshmukh AA
    Lancet Public Health; 2020 Sep; 5(9):e484-e492. PubMed ID: 32707126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of provider recommendation for HPV vaccine among young adult men and women: findings from a cross-sectional survey.
    Gerend MA; Shepherd MA; Lustria ML; Shepherd JE
    Sex Transm Infect; 2016 Mar; 92(2):104-7. PubMed ID: 26297720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey.
    Ylitalo KR; Lee H; Mehta NK
    Am J Public Health; 2013 Jan; 103(1):164-9. PubMed ID: 22698055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of HPV vaccine initiation and provider recommendation among male adolescents, 2014 NIS-Teen.
    Landis K; Bednarczyk RA; Gaydos LM
    Vaccine; 2018 Jun; 36(24):3498-3504. PubMed ID: 29752025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parent report of provider HPV vaccine communication strategies used during a randomized, controlled trial of a provider communication intervention.
    Dempsey AF; Pyrzanowski J; Campagna EJ; Lockhart S; O'Leary ST
    Vaccine; 2019 Feb; 37(10):1307-1312. PubMed ID: 30733088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative contributions of parental intention and provider recommendation style to HPV and meningococcal vaccine receipt.
    Eun TJ; Hanchate A; Fenton AT; Clark JA; Aurora MN; Drainoni ML; Perkins RB
    Hum Vaccin Immunother; 2019; 15(10):2460-2465. PubMed ID: 30862301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Provider Recommendation and Human Papillomavirus Vaccination Initiation among Male Adolescents Aged 13-17 Years-United States.
    Lu PJ; Yankey D; Fredua B; O'Halloran AC; Williams C; Markowitz LE; Elam-Evans LD
    J Pediatr; 2019 Mar; 206():33-41.e1. PubMed ID: 30448270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health.
    Lau M; Lin H; Flores G
    Vaccine; 2012 Apr; 30(20):3112-8. PubMed ID: 22425179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and predictors of human papillomavirus (HPV) vaccination among young women surviving childhood cancer.
    Klosky JL; Favaro B; Peck KR; Simmons JL; Russell KM; Green DM; Hudson MM
    J Cancer Surviv; 2016 Jun; 10(3):449-56. PubMed ID: 26572902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal uptake of human papillomavirus (HPV) vaccine in survivors of childhood and adolescent and young adult (AYA) cancer.
    Castellino SM; Allen KE; Pleasant K; Keyes G; Poehling KA; Tooze JA
    J Cancer Surviv; 2019 Oct; 13(5):730-738. PubMed ID: 31342304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls.
    Vadaparampil ST; Staras SA; Malo TL; Eddleton KZ; Christie J; Rodriguez M; Giuliano AR; Shenkman EA
    Cancer; 2013 Feb; 119(3):621-8. PubMed ID: 23341308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provider communication and HPV vaccination: The impact of recommendation quality.
    Gilkey MB; Calo WA; Moss JL; Shah PD; Marciniak MW; Brewer NT
    Vaccine; 2016 Feb; 34(9):1187-92. PubMed ID: 26812078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in Provider Recommendation of Human Papillomavirus Vaccination for U.S. Adolescents.
    Mohammed KA; Geneus CJ; Osazuwa-Peters N; Adjei Boakye E; Tobo BB; Burroughs TE
    J Adolesc Health; 2016 Nov; 59(5):592-598. PubMed ID: 27506278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why are U.S. girls getting meningococcal but not human papilloma virus vaccines? Comparison of factors associated with human papilloma virus and meningococcal vaccination among adolescent girls 2008 to 2012.
    Perkins RB; Lin M; Silliman RA; Clark JA; Hanchate A
    Womens Health Issues; 2015; 25(2):97-104. PubMed ID: 25747517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a provider-focused intervention for maximizing human papillomavirus (HPV) vaccine uptake in young cancer survivors receiving follow-up care in pediatric oncology practices: protocol for a cluster-randomized trial of the HPV PROTECT intervention.
    Landier W; Bhatia S; Richman JS; Campos Gonzalez PD; Cherven B; Chollette V; Aye J; Castellino SM; Gramatges MM; Lindemulder S; Russell TB; Turcotte LM; Colditz GA; Gilkey MB; Klosky JL
    BMC Pediatr; 2022 Sep; 22(1):541. PubMed ID: 36096775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provider perspectives on multilevel barriers to HPV vaccination.
    Lake PW; Kasting ML; Christy SM; Vadaparampil ST
    Hum Vaccin Immunother; 2019; 15(7-8):1784-1793. PubMed ID: 30779687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of Parent- and Provider-Reported Human Papillomavirus Vaccination of Adolescents.
    Adjei Boakye E; Tobo BB; Osazuwa-Peters N; Mohammed KA; Geneus CJ; Schootman M
    Am J Prev Med; 2017 Jun; 52(6):742-752. PubMed ID: 27890518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.